Korean Stock Insight
KOSPI Falls 1.79% on August 28 as Tech Selling Meets Refining and Beauty Strength
Korean equities delivered a sharp split between headline indices and underlying breadth on August 28. The KOSPI lost 123.49 points, or 1.79%, to close at 6,788.88 and ended a three-session winning streak. The KOSDAQ, however, gained 0.76 point, or 0.09%, to 838.41. The won strengthened by 8.4 won to 1,372.5 per U.S. dollar.
Concentrated large-cap selling drove the index shock
KOSPI turnover was 287.6 million shares worth about KRW 19.9 trillion. Foreign and institutional investors were reported as combined net sellers of roughly KRW 2 trillion, while retail investors bought a net KRW 424.36 billion. Concern about possible new U.S. semiconductor tariffs and caution before the Jackson Hole keynote encouraged profit-taking in the largest technology names.
SK hynix fell 4.45% to KRW 1,653,000 and Samsung Electronics lost 3.38% to KRW 257,000. Their index weight meant that the two declines shaped both the direction and the size of the KOSPI move. The next session will test whether more specific tariff information and foreign cash-market flows can stabilize the chip leaders.
Two pockets of strength survived the selloff
Refining and cosmetics moved independently from large-cap growth stocks. S-Oil climbed 9.14% to KRW 149,200 as Middle East tensions renewed attention on the refining complex. APR rose 6.21% to KRW 461,500 on earnings momentum. The contrast suggests that capital was not simply rotating into low-priced laggards; it favored companies with an identifiable earnings or event catalyst.
Biotech investors repriced financing risk
Samsung Biologics dropped 6.65% to KRW 1,486,000 after announcing a KRW 3 trillion rights offering. Even when new capital supports long-term investment, the size, issue terms and dilution to existing shareholders can dominate the short-term share-price response.
Breadth was firmer than the KOSPI headline
Advancers on the main board outnumbered decliners by 638 to 237, and the KOSDAQ held a small gain. That makes the session better understood as a repricing of risk in chip and biotech heavyweights than as a synchronized market breakdown. The next priorities are post-Jackson Hole rate expectations, semiconductor tariff headlines, foreign flows and continued KOSDAQ relative strength.
Bottom line: the index sold off, but the market underneath it held up better. Investors should first look for stabilization in large-cap semiconductors while separating explainable relative strength in refining and K-beauty from short-lived defensive trading.
Related KSI Research
- KOSPI Crash on August 19: How U.S. and Japanese Bond Yields Hit Korean Stocks
- Korea Stock Market Rally: Is This a Bottom or an Earnings-Season Rebound?
- Samsung and SK Hynix Rebound: A Bottom or Just Another Volatile Day?
